Serum HBsAg and ddPCR HBV-DNA as predictive parameters of HBsAg loss after nucleo (s)tide analogue (NA) treatment discontinuation in non-cirrhotic patients with chronic hepatitis B

Anna Francesca Guerra, Giovanni Tomassoli,Lorenzo Piermatteo,Stefano D'Anna,Romina Salpini,Valentina Svicher,Paolo Ventura,Gian Luca Abbati,Antonello Pietrangelo

Digestive and Liver Disease（2022）

引用 0|浏览17

暂无评分

摘要

Introduction: Stopping nucleo(s)tide analogue (NA) treatment in selected non-cirrhotic Chronic Hepatitis B (CHB) often leads to virus-induced flares, which may result to life-threatening liver failure.

查看译文

关键词

serum hbsag,hepatitis,hbsag loss,hbv-dna,non-cirrhotic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要